Why understanding the differences between Type 1 and Type 2 diabetes is essential for better health management and effective ...

Scientists have pinpointed and described unusual subtypes of fat cells that may help scientists explain why gut fat is linked ...

The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog, to improve glycemic control in patients with diabetes mellitus.

In patients with type 2 diabetes, the risk for chronic kidney disease differed among users of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylurea.

The different types of diabetes-prediabetes, type 1, type 2, type 1.5-have different courses of treatment and management. But ...

Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced that it will feature two oral presentations, one poster presentation, and chair ...

The US FDA has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with diabetes.

Learn how type 1 and type 2 diabetes differ in causes, onset, and management strategies. Expert insights on symptoms, ...

Tandem Diabetes Care has secured a new FDA clearance for its insulin dose-calculating algorithm, opening up its use to adults ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Researchers fed mice food containing 0.15% aspartame for 12 weeks, the equivalent of consuming three cans of diet soda daily ...